Intracerebroventricular and intravenous administration of synthetic DSIP in rabbits and rats has been reported to increase the proportion of EEG delta activity and slow-wave sleep without consistently suppressing REM (paradoxical) sleep (Schoenenberger & Monnier, 1977
While your body produces it on its own, levels can decline with age
TB-500 and Thymosin Beta-4 are also prohibited by WADA/USADA under S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), applicable at all times both in-competition and out-of-competition TB-500 / Thymosin Beta-4 Clinical Trials: The RGN-352 and RGN-259 Programs RegeneRx Biopharmaceuticals has pursued two clinical development programs for Thymosin Beta-4, providing the most substantial human clinical data available for any TB-500-related compound: RGN-352 (Injectable Thymosin Beta-4 for Cardiac Repair): Phase 1 trial (completed): A double-blind, placebo-controlled study enrolled 40 healthy volunteers across four cohorts of 10 subjects each, testing escalating dose levels of intravenous Thymosin Beta-4 administered daily over 14 days
Glutathione injections may help by reducing melanin production and encouraging a more even skin tone
M2 CHEMICAL AND PHYSICAL MANIPULATION All times All prohibited methods in this class are non -Specified except methods in M2.2
